Ozempic and other GLP-1 RAs could slow progression of some cancers, data suggest

Real-world data show that GLP-1 receptor agonists (GLP-1s) may reduce metastatic progression of certain obesity-related ...

GLP-1 drugs may lower risk of some cancers spreading, study suggests

A Cleveland Clinic study suggests GLP-1 weight loss drugs may help slow the spread of some obesity-related cancers.
MedPage Today on MSN

GLP-1s Linked to Lower Risk of Cancer Spread in Four Tumor Types

Accumulating evidence of possible benefit warrants randomized trials, experts say ...
IFLScience

One Drug Stopped Progression Of Many Types Of Cancer In Small Trial

Stephen has degrees in science (Physics major) and arts (English Literature and the History and Philosophy of Science), as well as a Graduate Diploma in Science Communication. Stephen has degrees in ...

GLP-1 Weight Loss Drugs May Reduce the Chance of Certain Cancers Progressing, New Study Suggests

GLP-1 medications were initially developed and prescribed to help manage blood sugar in people with Type 2 diabetes ...
Targeted Oncology

GLP-1 Agonists Associated With Major Reduction in Metastatic Cancer Progression

NSCLC showed the largest reduction in metastatic progression with GLP-1RAs versus gliptins (HR 0.50), with significant ...
Monthly Prescribing Reference

Tirzepatide Reduces the Risk of Progression to Type 2 Diabetes

Patients who discontinued tirzepatide during the 17-week off-treatment period began to regain weight. Tirzepatide significantly reduced the risk of progression to type 2 diabetes in adults with ...
Healio

Baseline glucose, increasing BMI predict progression to type 2 diabetes for children

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...